HSC Section 8_April 2017

operative hearing, cholesteatoma recurrence, and status of re- aeration of reconstructed middle-ear cavity. J Laryngol Otol 2003;117: 249–255. 24. Gerlach H. Is the “second look” justified after cholesteatoma surgery according to the closed technique? (our concept of “indicator-pearl”). Lar- yngol Rhinol Otol (Stuttg) 1982;61:294–296. 25. Elefante A, Cavaliere M, Russo C, et al. Diffusion weighted MR imaging of primary and recurrent middle ear cholesteatoma: an assessment by readers with different expertise. Biomed Res Int 2015;2015:597896. 26. Quaranta N, Iannuzzi L, Petrone P, D’Elia A, Quaranta A. Quality of life after cholesteatoma surgery: intact-canal wall tympanoplasty versus canal wall-down tympanoplasty with mastoid obliteration. Ann Otol Rhi- nol Laryngol 2014;123:89–93. 27. Vartiainen E. Factors associated with recurrence of cholesteatoma. J Laryngol Otol 1995;109:590–592. 28. Lynrah ZA, Bakshi J, Panda NK, Khandelwal NK. Aggressiveness of pedi- atric cholesteatoma. Do we have an evidence? Indian J Otolaryngol Head Neck Surg 2013;65:264–268. 29. Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors for residual disease and hearing outcomes. Arch Otolaryngol Head Neck Surg 2012;138:280–285. 30. Visvanathan V, Kubba H, Morrissey MS. Cholesteatoma surgery in chil- dren: 10-year retrospective review. J Laryngol Otol 2012;126:450–453. 31. Ahn SH, Oh SH, Chang SO, Kim CS. Prognostic factors of recidivism in pediatric cholesteatoma surgery. Int J Pediatr Otorhinolaryngol 2003;67: 1325–1330. 32. Lazard DS, Roger G, Denoyelle F, Chauvin P, Garabedian EN. Congenital cholesteatoma: risk factors for residual disease and retraction pockets— a report on 117 cases. Laryngoscope 2007;117:634–637. 33. Stangerup SE, Drozdziewicz D, Tos M. Cholesteatoma in children, predic- tors and calculation of recurrence rates. Int J Pediatr Otorhinolaryngol 1999;49(suppl 1):S69–S73. 34. Roger G, Denoyelle F, Chauvin P, Schlegel-Stuhl N, Garabedian EN. Pre- dictive risk factors of residual cholesteatoma in children: a study of 256 cases. Am J Otol 1997;18:550–558. 35. Iino Y, Imamura Y, Kojima C, Takegoshi S, Suzuki JI. Risk factors for recurrent and residual cholesteatoma in children determined by second stage operation. Int J Pediatr Otorhinolaryngol 1998;46:57–65. 36. Roux A, Bakhos D, Lescanne E, Cottier JP, Robier A. Canal wall recon- struction in cholesteatoma surgeries: rate of residual. Eur Arch Otorhi- nolaryngol 2014. Epub ahead of print. 37. Muir Gray, JA. Evidence-Based Healthcare and Public Health: How to Make Decisions About Health Services and Public Health. Edinburgh, Scotland; New York, NY: Churchill Livingstone/Elsevier; 2009.

5. Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol 2013;18: 135–142. 6. Brown JS. A ten year statistical follow-up of 1142 consecutive cases of cho- lesteatoma: the closed vs. the open technique. Laryngoscope 1982;92: 390–396. 7. Nyrop M, Bonding P. Extensive cholesteatoma: Long-term results of three surgical techniques. J Laryngol Otol 1997;111:521–526. 8. Kos MI, Castrillon R, Montandon P, Guyot JP. Anatomic and functional long-term results of canal wall-down mastoidectomy. Ann Otol Rhinol Laryngol 2004;113:872–876. 9. Jackler RK. The surgical anatomy of cholesteatoma. Otolaryngol Clin North Am 1989;22:883–896. 10. Neudert M, Lailach S, Lasurashvili N, Kemper M, Beleites T, Zahnert T. Cholesteatoma recidivism: comparison of three different surgical techni- ques. Otol Neurotol 2014;35:1801–1808. 11. Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cho- lesteatoma management. Eur Arch Otorhinolaryngol. 2014. Epub ahead of print. 12. Abramson M, Lachenbruch PA, Press BH, McCabe BF. Results of conservative surgery for middle ear cholesteatoma. Laryngoscope 1977;87:1281–1287. 13. Yang WY, Watson C. Post-operative follow up of cholesteatoma-how long is adequate? Clin Otolaryngol 2012;37:160. 14. Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term results. J Laryngol Otol 1989;103:149–157. 15. Stankovic M. Follow-up of cholesteatoma surgery: open versus closed tym- panoplasty. ORL J Otorhinolaryngol Relat Spec 2007;69:299–305. 16. Cochrane Handbook . 9.5.2 identifying and measuring heterogeneity. http:// handbook.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_het- erogeneity.htm. Accessed January 13, 2015. 17. Charachon R, Roux O, Eyraud S. Cholesteatoma of the middle ear. Choice of technique and results in the adult and child. Ann Otolaryngol Chir Cervicofac 1980;97:65–78. 18. Roden D, Honrubia VF, Wiet R. Outcome of residual cholesteatoma and hearing in mastoid surgery. J Otolaryngol 1996;25:178–181. 19. Ajalloueyan M. Surgery in cholesteatoma: ten years follow-up. Iran J Med Sci 2006;31:37–40. 20. Palmgren O. Long-term results of open cavity and tympanomastoid sur- gery of the chronic ear. Acta Otolaryngol 1979;88:343–349. 21. House WF, Sheehy JL. Functional restoration in tympanoplasty. Arch Oto- laryngol 1963;78:304–309. 22. Quaranta A, Cassano P, Carbonara G. Cholesteatoma surgery: Open vs closed tympanoplasty. Am J Otol 1988;9:229–231. 23. Ikeda M, Yoshida S, Ikui A, Shigihara S. Canal wall down tympanoplasty with canal reconstruction for middle-ear cholesteatoma: post-

Laryngoscope 126: April 2016

Kerckhoffs et al.: A Review on Cholesteatoma Recidivism After CWU and CWD

112